Lung cancer is the most common cause of cancer-associated mortality in China with 85% of
patients having non-small cell lung cancer (NSCLC). Identifying NSCLC driver genes and …

Background Retinoblastoma binding protein 4 (RBBP4) plays an essential role in the
development of multiple cancers. However, its relationship with prognosis in colon cancer …

Abstract Retinoblastoma binding protein 6 (RBBP6) is a cancer-related protein that has
been implicated in the regulation of cell cycle and apoptosis. RBBP6 isoform 1 has been …

Hepatocellular carcinoma (HCC) is one of the most common malignancy tumors with
insidious onset, rapid development and metastasis, and poor prognosis. Therefore, it is …

Retinoblastoma binding protein 6 (RBBP6) interacts with both p53 and pRb, and has been
identified as an E3 ubiquitin ligase due to the presence of a RING finger domain. RBBP6 …

Previous studies have shown that retinoblastoma binding protein 6 (RBBP6) was
overexpressed in malignant tumors and was correlated with poorer prognosis in various …

Background Non‐small‐cell lung cancer (NSCLC) often presents at later stages, typically
associated with poor prognosis. Autophagy genes play a role in the progression of tumors …

Background Pathological angiogenesis plays an essential role in tumor aggressiveness and
leads to unfavorable prognosis. The aim of this study is to detect the potential role of …

Background Recently, some studies have found that retinoblastoma-binding protein 2
(RBP2) is involved in the development and progression of many kinds of malignant tumors …

Abstract Retinoblastoma‑binding protein 7 (RBBP7) is an important component of several
complexes that regulate chromatin metabolism. It is overexpressed in certain cancer types …